The next corporations are anticipated to report earnings previous to market open on 02/03/2023. Go to our Earnings Calendar for a full checklist of anticipated earnings releases.
Sanofi (SNY)is reporting for the quarter ending December 31, 2022. The big cap pharmaceutical firm’s consensus earnings per share forecast from the 4 analysts that comply with the inventory is $0.90. This worth represents a 13.92% improve in comparison with the identical quarter final 12 months. Prior to now 12 months SNY has beat the expectations each quarter. The very best one was within the third calendar quarter the place they beat the consensus by 9.85%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for SNY is 11.28 vs. an trade ratio of 17.00.
Cigna Company (CI)is reporting for the quarter ending December 31, 2022. The insurance coverage firm’s consensus earnings per share forecast from the ten analysts that comply with the inventory is $4.84. This worth represents a 1.47% improve in comparison with the identical quarter final 12 months. Prior to now 12 months CI has beat the expectations each quarter. The very best one was within the third calendar quarter the place they beat the consensus by 5.96%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for CI is 13.54 vs. an trade ratio of -226.80, implying that they may have a better earnings progress than their opponents in the identical trade.
Regeneron Prescription drugs, Inc. (REGN)is reporting for the quarter ending December 31, 2022. The biomedical (gene) firm’s consensus earnings per share forecast from the 7 analysts that comply with the inventory is $8.18. This worth represents a 65.51% lower in comparison with the identical quarter final 12 months. Prior to now 12 months REGN has beat the expectations each quarter. The very best one was within the third calendar quarter the place they beat the consensus by 16.73%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for REGN is 20.09 vs. an trade ratio of 4.00, implying that they may have a better earnings progress than their opponents in the identical trade.
Aon plc (AON)is reporting for the quarter ending December 31, 2022. The insurance coverage brokers firm’s consensus earnings per share forecast from the 7 analysts that comply with the inventory is $3.67. This worth represents a 1.08% lower in comparison with the identical quarter final 12 months. AON missed the consensus earnings per share within the 1st calendar quarter of 2022 by -0.62%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for AON is 24.27 vs. an trade ratio of twenty-two.80, implying that they may have a better earnings progress than their opponents in the identical trade.
LyondellBasell Industries NV (LYB)is reporting for the quarter ending December 31, 2022. The chemical firm’s consensus earnings per share forecast from the 9 analysts that comply with the inventory is $1.09. This worth represents a 69.97% lower in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for LYB is 7.93 vs. an trade ratio of 14.10.
Zimmer Biomet Holdings, Inc. (ZBH)is reporting for the quarter ending December 31, 2022. The medical merchandise firm’s consensus earnings per share forecast from the 12 analysts that comply with the inventory is $1.83. This worth represents a 6.15% lower in comparison with the identical quarter final 12 months. ZBH missed the consensus earnings per share within the 4th calendar quarter of 2021 by -0.51%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for ZBH is eighteen.68 vs. an trade ratio of 9.30, implying that they may have a better earnings progress than their opponents in the identical trade.
Church & Dwight Firm, Inc. (CHD)is reporting for the quarter ending December 31, 2022. The cleansing firm’s consensus earnings per share forecast from the ten analysts that comply with the inventory is $0.60. This worth represents a 6.25% lower in comparison with the identical quarter final 12 months. Prior to now 12 months CHD has beat the expectations each quarter. The very best one was within the third calendar quarter the place they beat the consensus by 16.92%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for CHD is 27.59 vs. an trade ratio of 23.30, implying that they may have a better earnings progress than their opponents in the identical trade.
Avantor, Inc. (AVTR)is reporting for the quarter ending December 31, 2022. The medical companies firm’s consensus earnings per share forecast from the 9 analysts that comply with the inventory is $0.30. This worth represents a 16.67% lower in comparison with the identical quarter final 12 months. AVTR missed the consensus earnings per share within the 2nd calendar quarter of 2022 by -2.63%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for AVTR is 17.58 vs. an trade ratio of -7.00, implying that they may have a better earnings progress than their opponents in the identical trade.
Cboe International Markets, Inc. (CBOE)is reporting for the quarter ending December 31, 2022. The securities alternate firm’s consensus earnings per share forecast from the 6 analysts that comply with the inventory is $1.77. This worth represents a 4.12% improve in comparison with the identical quarter final 12 months. CBOE missed the consensus earnings per share within the 2nd calendar quarter of 2022 by -1.76%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for CBOE is 17.81 vs. an trade ratio of 20.80.
Brookfield Renewable Companions L.P. (BEP)is reporting for the quarter ending December 31, 2022. The electrical energy utilities firm’s consensus earnings per share forecast from the three analysts that comply with the inventory is $-0.04. This worth represents a 66.67% improve in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for BEP is -159.33 vs. an trade ratio of -1.40.
Saia, Inc. (SAIA)is reporting for the quarter ending December 31, 2022. The truck firm’s consensus earnings per share forecast from the 6 analysts that comply with the inventory is $2.80. This worth represents a 1.45% improve in comparison with the identical quarter final 12 months. SAIA missed the consensus earnings per share within the third calendar quarter of 2022 by -0.27%. The “days to cowl” for this inventory exceeds 10 days. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for SAIA is 21.82 vs. an trade ratio of 15.30, implying that they may have a better earnings progress than their opponents in the identical trade.
Brookfield Renewable Company (BEPC)is reporting for the quarter ending December 31, 2022. The choice vitality firm’s consensus earnings per share forecast from the 1 analyst that follows the inventory is $-0.15. This worth represents a 25.00% lower in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for BEPC is -65.04 vs. an trade ratio of 24.70.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
